Advertisement

Archives of Gynecology and Obstetrics

, Volume 254, Issue 1–4, pp 592–594 | Cite as

Die Behandlung der Endometriose mit einem langwirksamen, injizierbaren LH-RH-Analogon (Buserelin)

  • I. Wiegratz
  • M. Dannhof
  • R. Baumann
  • H. -D. Taubert
Gynäkologie Endometriose
  • 16 Downloads

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Barbieri, R.L.: Etiology and epidemiology of endometriosis Am. J. Obstet. Gynecol. 162, 565–567, 1990PubMedGoogle Scholar
  2. 2.
    Buttram, V.C. jr.: Evolution of the Revised American Fertility Society Classification of Endometriosis Fertil Steril 43, 347–350, 1985PubMedGoogle Scholar
  3. 3.
    Evers, J.L.H.: The second-look laparoscopy for evaluation of the result of medical treatment of endometriosis should not be performed during ovarian suppression Fertil Steril 47, 502–504, 1987PubMedGoogle Scholar
  4. 4.
    Brown, J.B.: Gonadotropins In: Infertility. Male and Female, p. 359, Insler, V., Lunenfeld, B. (eds.) Edinburgh, Churchill Livindston 1986Google Scholar
  5. 5.
    Fraser, H.M., Sandow, J., Seidel, H., v.Rechenberg, W.: An implant of agonadotropin releasing hormone agonist (buserelin) which suppresses ovarian function in the macaque for 3–5 month Acta Endocrinol (Copenh) 115, 521–527, 1987PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1993

Authors and Affiliations

  • I. Wiegratz
    • 1
  • M. Dannhof
    • 1
    • 2
  • R. Baumann
    • 1
    • 2
  • H. -D. Taubert
    • 1
    • 2
  1. 1.Universitäts-Frauenklinik Frankfurt, Abteilung für Gynäkologie und gynäkologische OnkologieGermany
  2. 2.Abteilung für EndokrinologieFrankfurt

Personalised recommendations